Panacea Biotec Ltd (PANACEABIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 622974, "name": "Panacea Biotec", "stock_name": "Panacea Biotec", "full_name": "Panacea Biotec Ltd", "name_url": "stocks-analysis/panacea-biotec", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "543.05", "chg": -22.8, "chgp": "-4.03%", "dir": -1, "prev_price": "565.85", "mcapval": "3,614.00 Cr", "mcap": "Small Cap", "scripcode": 531349, "symbol": "PANACEABIO", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE922B01023", "curr_date": "Jul 01, 03:30 PM", "curr_time": "18:37 PM", "last_traded_at": "Jul 01, 03:30 PM IST", "bse_nse_vol": "10.32 lacs", "exc_status": "Active", "traded_date": "Jul 01, 2026", "traded_date_str": "2026 07 01", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Panacea Biotec Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-sell-4078816", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_mojoScore_4078816.png", "date": "2026-06-30 10:10:03", "description": "Panacea Biotec Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Panacea Biotec Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-indicators-4077854", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_technicaldot_4077854.png", "date": "2026-06-30 08:04:29", "description": "Panacea Biotec Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a day-on-day price decline of 1.30%, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This article analyses the recent technical developments, key momentum indicators, and the stock’s performance relative to the broader market." }, { "title": "Panacea Biotec Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4076358", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_technicaldot_4076358.png", "date": "2026-06-29 08:01:46", "description": "Panacea Biotec Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, as reflected in a complex interplay of technical indicators. Despite a modest day gain of 0.80%, the stock’s weekly and monthly charts reveal contrasting signals, underscoring a nuanced outlook for investors in this small-cap pharmaceutical and biotechnology player." }, { "title": "Panacea Biotec Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/panacea-biotec-ltd-is-rated-sell-by-marketsmojo-4063265", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_mojoScore_4063265.png", "date": "2026-06-19 10:10:04", "description": "Panacea Biotec Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Jun 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Panacea Biotec Surges 31.21% in Volatile Week: Key Technical Shifts and Earnings Impact", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-surges-3121-in-volatile-week-key-technical-shifts-and-earnings-impact-4052378", "imagepath": "", "date": "2026-06-13 17:21:59", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Q4 FY26 results reveal losses and collapsing operating margins despite revenue growth</p>\n <p><strong>2 June:</strong> Intraday high surge of 8.26% and downgrade to Strong Sell by MarketsMOJO</p>\n <p><strong>3 June:</strong> Technical upgrade to Sell amid improving momentum despite weak fundamentals</p>\n <p><strong>4 June:</strong> Strong intraday rally of 8.78%, hitting Rs.476.25</p>\n <p><strong>5 June:</strong> Week closes at Rs.541.10, up 3.96% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label..." }, { "title": "Panacea Biotec Ltd’s Volatile Week: 9.98% Surge and 9.99% Plunge Highlight Market Dynamics", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltds-volatile-week-998-surge-and-999-plunge-highlight-market-dynamics-4051379", "imagepath": "", "date": "2026-06-13 13:01:07", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 Jun:</strong> Mojo Grade upgraded to Sell amid technical improvements</p>\n <p><strong>9 Jun:</strong> New 52-week and all-time highs at Rs.619.05 and Rs.608.8</p>\n <p><strong>10 Jun:</strong> Sharp plunge to lower circuit amid heavy selling</p>\n <p><strong>12 Jun:</strong> Week closes at Rs.537.30, down 0.70%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.553.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.537.30</div><..." }, { "title": "Panacea Biotec Ltd Locks at Lower Circuit With 9.87% Loss — Sellers Queue, No Buyers in Sight", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-4044355", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_stocks_hitting_lower_circuit_4044355.png", "date": "2026-06-10 15:00:08", "description": "At Rs 547.75, sellers were still queuing — but there were no buyers willing to take the other side. Panacea Biotec Ltd locked at its lower circuit of 9.87% on 10 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand." }, { "title": "Panacea Biotec Ltd Hits Intraday Low Amid Price Pressure on 10 Jun 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-hits-intraday-low-amid-price-pressure-on-10-jun-2026-4043635", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_priceRelatedfactors_4043635.png", "date": "2026-06-10 09:31:56", "description": "Panacea Biotec Ltd experienced a notable decline today, touching an intraday low of Rs 573.85, reflecting a sharp price correction amid heightened volatility and broader market dynamics. The stock underperformed its sector and reversed a six-day gaining streak, signalling immediate pressures on its intraday performance." }, { "title": "Panacea Biotec Ltd Sees Strong Technical Momentum Amid Market Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-ltd-sees-strong-technical-momentum-amid-market-rally-4043290", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PanaceaBiotecLt_technicaldot_4043290.png", "date": "2026-06-10 08:03:28", "description": "Panacea Biotec Ltd has demonstrated a remarkable shift in price momentum, transitioning from a sideways trend to a bullish trajectory, supported by a confluence of positive technical indicators. The stock’s recent surge, marked by a 9.98% gain on 10 Jun 2026, reflects renewed investor confidence amid broader market challenges, with the company outperforming the Sensex significantly across multiple time horizons." } ], "total": 289, "sid": "622974", "stock_news_url": "https://www.marketsmojo.com/news/panacea-biotec-622974" }, "announcements": [ { "details": "Panacea Biotec Limited has informed the Exchange regarding 'Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding publication of Extract of Statement of Unaudited Financial Results for the quarter and half year ended 30.09.2019'.", "source": "NSE", "caption": "Panacea Biotec Limited - Updates", "datetime": "18-Nov-2019" }, { "details": "Panacea Biotec Limited has informed the Exchange regarding Board meeting held on November 14, 2019.", "source": "NSE", "caption": "Panacea Biotec Limited - Outcome of Board Meeting", "datetime": "15-Nov-2019" }, { "details": "Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during October, 2019 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.", "source": "NSE", "caption": "Panacea Biotec Limited - Updates", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11", "dt": "2011-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Q4 FY26 results reveal losses and collapsing operating margins despite revenue growth

2 June: Intraday high surge of 8.26% and downgrade to Strong Sell by MarketsMOJO

3 June: Technical upgrade to Sell amid improving momentum despite weak fundamentals

4 June: Strong intraday rally of 8.78%, hitting Rs.476.25

5 June: Week closes at Rs.541.10, up 3.96% on the day

Read full news article

Panacea Biotec Ltd’s Volatile Week: 9.98% Surge and 9.99% Plunge Highlight Market Dynamics

2026-06-13 13:01:07

Key Events This Week

8 Jun: Mojo Grade upgraded to Sell amid technical improvements

9 Jun: New 52-week and all-time highs at Rs.619.05 and Rs.608.8

10 Jun: Sharp plunge to lower circuit amid heavy selling

12 Jun: Week closes at Rs.537.30, down 0.70%

Read full news article

Panacea Biotec Ltd Locks at Lower Circuit With 9.87% Loss — Sellers Queue, No Buyers in Sight

2026-06-10 15:00:08

At Rs 547.75, sellers were still queuing — but there were no buyers willing to take the other side. Panacea Biotec Ltd locked at its lower circuit of 9.87% on 10 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

Read full news article

Panacea Biotec Ltd Hits Intraday Low Amid Price Pressure on 10 Jun 2026

2026-06-10 09:31:56

Panacea Biotec Ltd experienced a notable decline today, touching an intraday low of Rs 573.85, reflecting a sharp price correction amid heightened volatility and broader market dynamics. The stock underperformed its sector and reversed a six-day gaining streak, signalling immediate pressures on its intraday performance.

Read full news article

Panacea Biotec Ltd Sees Strong Technical Momentum Amid Market Rally

2026-06-10 08:03:28

Panacea Biotec Ltd has demonstrated a remarkable shift in price momentum, transitioning from a sideways trend to a bullish trajectory, supported by a confluence of positive technical indicators. The stock’s recent surge, marked by a 9.98% gain on 10 Jun 2026, reflects renewed investor confidence amid broader market challenges, with the company outperforming the Sensex significantly across multiple time horizons.

Read full news article

View All News